Medical Devices

LivingPHOENIX claims to have solved the terminal sterilization bottleneck for synthetic collagen. David Patterson examines the tech, IP, and execution strategy.

RIVANNA's newly FDA-cleared BoneEnhance software brings AI-driven 3D anatomical mapping to the ER, promising to reshape how we triage musculoskeletal injuries.

A new integrated platform wowed surgeons at AAO 2026 with ultra-low latency and AI, but ambitious regulatory timelines pose a significant hurdle.

Five pioneers won the 2026 Merkin Prize for the cochlear implant. Their work didn't just restore hearing; it built the strategic foundation for modern BCIs.

As pediatric nearsightedness surges, new specialty lenses and therapies offer hope, but a glaring parental awareness gap and high costs threaten progress.

A new robotic system from abrobo moves beyond simple diagnostics, proving capable of executing complex, multi-device brain surgeries in a preclinical study.

Kane Biotech engages Independent Trading Group to narrow bid-ask spreads, signaling a strategic push to align capital markets with its commercial rollout.

Forma Medical’s newly patented MIPA technique adapts trauma surgery principles to elective joint fusion, creating a formidable IP moat in orthopedic care.

Swiss MedTech Distalmotion just secured a $70 million debt facility to expand its DEXTER robot in US surgery centers, signaling a shift in OR economics.

A decade-long partnership between Surgical Science and CHEST is replacing traditional medical apprenticeship with rigorous, data-driven virtual reality training.

As STERIS approaches its Q2 FY2027 earnings, all eyes are on the infection prevention giant's $600 million manufacturing overhaul and pending acquisitions.

As EBR Systems scales its leadless heart failure therapy, appointing a practicing clinician as CMO highlights the tension between innovation and bedside reality.

Empyrean Medical Systems targets the specialized brachytherapy market with its Vektra system, challenging medtech giants with new robotic precision.

A new partnership between Beacon Biosignals and Project Sleep aims to dismantle the 11-year diagnostic delay for hypersomnia using at-home AI neurotechnology.

As hospital demand surges, a new wave of automated whole-blood processing is stabilizing the fragile U.S. platelet supply chain across the Midwest.

Enable Injections and Sanofi secure Japan’s first approval for an oncology on-body injector, shifting multiple myeloma treatment from the clinic to the consumer.

As sub-Saharan Africa battles a severe cervical cancer crisis, offline edge AI is stepping in where traditional labs fall short to bridge the diagnostic divide.

As the era of cheap capital ends, private equity is tapping veteran operators to drive organic growth. Inside Todd Cooper’s strategic move to the deal team.

At the 2026 Collegiate Inventors Competition, a new wave of student-led medical technologies proves that impact matters more than consumer hype.

Sequel Med Tech’s twiist system just gained FDA clearance for type 2 diabetes, signaling a massive shift in how millions will manage their insulin therapy.